| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a153f0a1b53fa754774ff1f85464faa6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca254cb6a2c92ef3429fd434c71a5d7d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167 |
| filingDate |
2010-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_748b8aa37c9c6851e494f2e62235d3e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03807056c34722ced3586d75bd43b28d |
| publicationDate |
2010-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010081984-A1 |
| titleOfInvention |
Formulation for oral transmucosal administration of analgesic and/or antispasmodic molecules |
| abstract |
The subject matter of the invention is a formulation for oral transmucosal administration of at least one active ingredient with an antispasmodic and/or analgesic action, comprising said active ingredient in the form of a base and/or in the form of a salt, and an aqueous-alcoholic solution with a titre of at least 35° of alcohol by mass, said active ingredient being stably and completely dissolved in the aqueous-alcoholic solution. The invention also relates to a method for preparing this formulation and to the use thereof for the treatment of spastic attacks. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11617730-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016116693-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018002535-A1 |
| priorityDate |
2009-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |